Risk Academy, led by the Nexus Consortium · Health and Society · Department of Global Health Security
Biosafety, biosecurity, dual-use oversight and neurotechnology governance
Biotegnologie, biosekuriteit en neurotegnologie
This field studies the governance of biological research and biotechnology: how institutions prevent accidental harm, deter misuse and keep oversight proportionate.
Map biotechnology, biosecurity and neurotechnology on a real placeSee the courses
Illustrative: two backbones and their base pairs, the major and minor grooves, a reading frame travelling along the strand
01Omvang
What the discipline covers
The subtopics its courses and labs teach.
- Department
- Department of Global Health Security
- Kursusse
- In preparation
- Vlakke
- In development
- Laboratoriums
- Network lab
- Laboratory biosafety and biosecurity
- Dual-use research oversight
- Synthetic biology governance
- Biomanufacturing risk
- Diagnostics and medical countermeasures
- Agricultural biotechnology
- Biological threat preparedness
- Ethics and responsible research
- Neurotechnology and neural data
Courses in development extend the scope to further subjects: Neurotechnology rights and governance; Biosecurity governance and oversight.
02Kaarte
Build a twin of any place
Search any place or open the world; the layers and generators follow biotechnology, biosecurity and neurotechnology on the planet map, the globe and in 3D.
- Terrain 191 to 315 m
- 950 hospitals
- 26,073,018 people in the box, 2020
- Population density, GPW v4.11 (2020): read live when the 3D twin opens
- Air quality, Copernicus CAMS via Open-Meteo (hourly, 5 days): read live when the 3D twin opens
- Nitrogen dioxide column, TROPOMI (Sentinel-5P): read live when the 3D twin opens
- Surface air temperature, AIRS (daily, day): read live when the 3D twin opens
- Urban heat island, summer daytime 2013: read live when the 3D twin opens
- Built-up and settlement extent, HBASE 2010: read live when the 3D twin opens
Drag to move, right drag or Shift with a drag to turn and tilt, Ctrl with the wheel to zoom. Keyboard: arrows move, Shift with arrows turn and tilt, + and – zoom, 0 resets, V steps through the views, Escape clears.
Flat plan of the same data: relief as contours from the inline grid, the WorldPop count grid as cells, the mapped hospitals and the numbers below. The 3D twin opens on devices that can draw it, once its data and code have been checked.
The boundaries, names and designations shown do not imply any judgement on the legal status of any territory, or any endorsement or acceptance of such boundaries. Countries: Natural Earth (public domain).
03The subject
The subject, methods and measures and debates and bodies
The discipline
The field and its scope
For laboratory directors, research funders, regulators and policy analysts who must govern life science research, biomanufacturing and neurotechnology proportionately to the risk.
This field studies the governance of biological research and biotechnology: how institutions prevent accidental harm, deter misuse and keep oversight proportionate. Biosafety concerns containment and the protection of workers, communities and the environment. Biosecurity concerns the security of biological materials and information, and the oversight of research whose results could be misapplied. Biotechnology governance covers synthetic biology, biomanufacturing, diagnostics, agricultural applications and, increasingly, the convergence of these fields with computational tools. The subject matter is institutional: who reviews, who screens, who reports, who decides, and on what evidence.
The field sits between microbiology, security studies, ethics, law and public administration. It is organised around the Biological Weapons Convention of 1972, which has no verification mechanism and a small implementation support unit; the WHO laboratory biosafety manual and its global guidance framework for the responsible use of the life sciences published in 2022; national frameworks for research of concern; and voluntary industry practice, including the screening of commercial gene synthesis orders. Neurotechnology enters as a governance subject through neural data, cognitive liberty and the regulation of devices, with UNESCO and the OECD setting early principles. Hazards in this chapter are named at category level only.
Measures
Quantities and units
| Quantity | Unit or scale | What to know |
|---|---|---|
| Containment level of a facility | biosafety level 1 to 4 | A classification of facilities and practices, not a measurement of risk. The fourth edition of the WHO laboratory biosafety manual moved to a risk-based approach in which controls follow an assessment rather than the agent's label alone. |
| Laboratory-acquired infections | reported incidents per year, or per 1,000 workers | Under-reported and collected without a common denominator. Published series come from voluntary surveys and literature reviews, so trends cannot be read as changes in underlying rates. |
| Biosafety and biosecurity capacity score | score 1 to 5 in the Joint External Evaluation | Scores legal frameworks, oversight arrangements and training rather than observed practice in laboratories. Evaluations are periodic and partly self-nominated, so comparisons across countries are indicative. |
| Coverage of gene synthesis order screening | share of providers and of orders screened | Known mainly from members of the International Gene Synthesis Consortium and from self-reports. Providers outside voluntary arrangements are not represented, so the published share overstates coverage of the market. |
| Institutional review throughput | proposals reviewed under dual-use policies per year | Published by some funders and institutions. The count depends on the definition used in each policy, so figures are not comparable between countries and omit unfunded and private work. |
Metodes
Methods and their limits
Each method is listed with what it assumes and where it fails.
| Metode | Assumes | Fails when |
|---|---|---|
| Biosafety risk assessment | That the hazard of an agent, the procedure, the scale of work and the competence of staff can be combined into a risk level matched to a set of controls, as in the WHO manual. | When the assessment is static while the work changes, when human factors such as fatigue and production pressure are left out, and when the institution rewards throughput over the reporting of near misses. |
| Dual-use research oversight | That a committee with scientific and security expertise can identify, before funding or publication, work whose results could be misapplied, and can attach conditions. | At the boundary between clearly benign and clearly concerning work, where most cases sit; when committees lack security expertise or time; and when equivalent knowledge is available from sources that no committee reviews. |
| Order and customer screening by synthesis providers | That orders can be checked against reference lists and that customers and institutions can be verified before material is shipped. | Where providers sit outside voluntary arrangements, where benchtop devices remove the provider from the transaction, and where reference lists lag behind the published literature. |
| Horizon scanning and technology assessment | That expert elicitation and literature monitoring can identify capabilities likely to change the risk picture within a few years, and rank them for attention. | When anchored on historical programmes rather than current practice, when expert panels share a discipline and miss adjacent fields, and when the output is a list with no owner for action. |
| Neural data governance assessment | That neural signals can be treated as personal data with identifiable inference risks, and that consent, purpose limitation and security controls can be applied to devices and datasets. | When consumer devices sit outside medical device regulation, when inference capability advances faster than the classification, and when neural data is combined with other sources that carry their own permissions. |
Debates
What the field debates
- How should oversight of research with pandemic potential be organised?
- One position holds that national funder policies and institutional committees, strengthened since 2024, give proportionate review close to the science and preserve the research that supports countermeasures. The other holds that review arriving after a project is designed and confined to publicly funded work leaves much of the field uncovered, and that an international mechanism with a common definition is needed. Both sides cite the absence of a verification mechanism under the Biological Weapons Convention.
- Does the convergence of computational tools and biology change the risk picture enough to warrant new controls?
- Some assessments argue that assistance at the design stage lowers barriers that once required tacit expertise, and they favour screening obligations at the point of material supply and evaluation requirements for capable models. Others argue that published evaluations have not shown a decisive change against an already accessible scientific literature, that physical and tacit barriers remain the binding constraint, and that broad controls would slow beneficial work without reducing the risk.
- Should neurotechnology be governed as a medical device, as a data regime, or as a human rights question?
- Device regulators argue that safety and efficacy frameworks already cover implanted and clinical systems and extend naturally to the rest. Data protection authorities argue that the decisive risk is inference from neural signals, which is a processing question regardless of device class. A third position, advanced through UNESCO's work on the ethics of neurotechnology, argues that mental privacy and cognitive liberty need explicit rights language because consent at the point of purchase cannot carry that weight.
Bodies and data
Bodies that set practice, and the data they publish
Bodies and standards are named so learners can find and apply their published work; the Academy teaches their use and links to the publisher, and no affiliation is implied.
| Body | Role in the field |
|---|---|
| World Health Organization | Publishes the laboratory biosafety manual and the global guidance framework for the responsible use of the life sciences, and supports national biosafety and biosecurity capacity. |
| Biological Weapons Convention Implementation Support Unit | Supports States Parties to the Convention, administers confidence-building measure submissions and services the meetings where oversight proposals are discussed. |
| International Biosecurity and Biosafety Initiative for Science | An independent body working on common screening practice for commercial gene synthesis and on support for providers that adopt it. |
| Nuclear Threat Initiative bio programme | Publishes analysis of biosecurity governance gaps and convenes work on international oversight mechanisms and synthesis screening. |
| UNESCO | Developed international standard-setting work on the ethics of neurotechnology, covering neural data, mental privacy and the governance of devices. |
| Organisation for Economic Co-operation and Development | Issued the recommendation on responsible innovation in neurotechnology and maintains work on biotechnology policy and biological resource infrastructure. |
| Dataset | Steward |
|---|---|
| Joint External Evaluation country reports | World Health Organization |
| Biological Weapons Convention documents and confidence-building measures | United Nations Office for Disarmament Affairs |
| Global Health Security Index | Nuclear Threat Initiative and Johns Hopkins Center for Health Security |
04Die metode
From an order to a review: how screening coverage and review capacity govern synthetic biology
Biosecurity governance is a pipeline with measurable stages: the share of gene synthesis orders that reach a provider who screens, the share of screened orders flagged for human review, and the number of reviews an oversight body can complete in a year; a gap at any stage is a number, and the decision is where to spend to close it.
Sources: World Health Organization, Global guidance framework for the responsible use of the life sciences (2022); National Academies of Sciences, Engineering, and Medicine, Biodefense in the age of synthetic biology (2018); National Research Council, Biotechnology research in an age of terrorism (2004); Lipsitch and Inglesby, Moratorium on research intended to create novel potential pandemic pathogens (2014).
05At a glance
At a glance, standards and evidence, research and evidence, what is changing and learning
- Build a twin of any placeTwin builderWorked example: Delhi and its National Capital Territory core · 5 generators · 11 layers · 3 instruments
3D-grafiek
Fakulteit vir Gesondheid en Samelewing
218 nodes1,500 relations9 views
06Konsole
How Biotechnology, biosecurity and neurotechnology is taught, as a process you can run
Press Play to run this process from this page's own data.
Biotegnologie, biosekuriteit en neurotegnologie
How Biotechnology, biosecurity and neurotechnology is taught
5 subjects in scope, 3 key terms, courses in development, 1 lab, in the Global Health Security department of Health and Society: from the scope to the method and its terms, the courses that teach it, the labs on the twin, the assessment and the record.
-
01 Scope
- 01
Laboratory biosafety…
Start · the discipline
Laboratory biosafety and biosecurity
- 02
Dual-use research…
Start · the discipline
Dual-use research oversight
- 03
Synthetic biology…
Start · the discipline
Synthetic biology governance
- 04
Biomanufacturing risk
Start · the discipline
Biomanufacturing risk
- 05
Diagnostics and medical…
Start · the discipline
Diagnostics and medical countermeasures
- 01
-
02 Method and terms
- 06
From an order to a…
Model · the learner
Biosecurity governance is a pipeline with measurable stages: the share of gene synthesis orders that reach a provider who screens, the…
- 07
Biosafety
Record · the discipline
Practices and controls that prevent unintended exposure to or release of biological agents.
- 09
Biosekuriteit
Record · the discipline
Measures that prevent the loss, theft or misuse of biological agents and knowledge.
- 11
Dual-use research of…
Record · the discipline
Life sciences research that could be misapplied to cause harm.
- 06
-
04 Labs
- 08
Tweeling
Exercise · the learner, on the faculty twin
The method runs on the faculty twin and the admitted map layers.
- 08
-
05 Assess
- 10
Module checks
Gate · the course
Each module ends with a short check against its outcomes.
- 12
Assessed work
Decision · the learner
The assessed work that closes a course: a lab record, a case memo or an assignment, reviewed against the rubric.
- 10
-
06 Record
- 13
Voltooiingsrekord
Outcome · the learner
The record stacks into the discipline achievement.
- 14
Discipline achievement
Record · the Academy
The discipline achievement follows the discipline rule, read from the records.
- 13
Biotechnology, biosecurity and neurotechnology · Global Health Security An outline of how the work is designed to run; it does not report the status of any decision or record.
07Praktyk
Practice, learning and connections
Technology in this area
How technology helps and what risk it brings
| Aspect | In this area |
|---|---|
| Technology that helps | AI-assisted diagnostics, genomic surveillance and digital health. |
| Risk technology creates | Ransomware in hospitals, AI medical device risk, biosecurity and neurotechnology. |
- RAN-316 Health Care Risk and Hospital Resilience In preparation
- RAT-260 AI Assurance, Audit and Conformity Assessment In development
- RAS-419 Biosecurity Governance and Oversight In development
- RAF-129 Neurotechnology: Rights, Privacy and Governance In development
Prestasies
Achievements in this discipline
Course achievements
One for each course with this as its primary discipline, earned when you pass the course's assessed activities.
Discipline: Biotechnology, biosecurity and neurotechnology
Complete 3 assessed courses in biotechnology, biosecurity and neurotechnology, at least 2 with it as their primary discipline and at least 1 at Intermediate (L2) or above, totalling at least 45 measured learning hours. In development.
Department: Global Health Security
Earn two discipline achievements in the Department of Global Health Security. In development.
Programme: Nexus-Based Risk Management flagship pathway
Complete every core course of the Nexus-Based Risk Management flagship pathway under assessed completion, ending with its capstone. In development.
An achievement is a record of the learning completed and assessed here. How recognition works.
Leerpaaie
Pathways that teach it
- Nexus-Based Risk Management flagship pathwayAcademy flagshipOne of its 20 courses is in this discipline.
- Public health emergency plannerRole pathwayOne of its 8 courses is in this discipline.
Where this is practised
Where the subject is practised
- The Global Centre for Risk and Innovation (GCRI Canada)Biotechnology and BiosecurityAgricultural biotechnology, Biological threats, Biomanufacturing, Diagnostics and therapeutics, Dual use and ethics, Lab biosafety and biosecurity, One health impacts, Synthetic biology
- The Global Risks Forum (GRF)Health and Biosecurity GovernanceBiological risk governance
Field platforms of the ecosystem where the subject is studied and applied.
Practised in
The two Foundry systems where it is practised
- FoundryNXS-NSF systemOversight of dual-use research through purpose constraints
- NXS-LAB systemResearch protocols and their limits
Foundry system pages describe what each system and its rooms are designed to do; the courses teach the methods these systems apply.
Across the ecosystem
Across the ecosystem
The science, platforms and standards this discipline draws on and contributes to across the ecosystem.
Foundations in the STEM Commons
- The Global Centre for Risk and Innovation (GCRI Canada)Biotechnology platformsBiotechnology platforms apply biological systems to produce medicines, diagnostics, materials and agricultural products.
- Molecular and life sciencesMolecular and life sciences study the structure and function of living systems from genes and proteins to cells and organisms.
- Epidemiology and public health scienceEpidemiology studies the distribution and determinants of health and disease in populations.
Standards for the field
- Nexus StandardsHealth and BiosecurityThe subsite that keeps the standards this discipline teaches.
- Digital, Cyber and AIThe subsite that keeps the standards this discipline teaches.
Pages of the ecosystem, cited so learners can follow the field into research, platforms, standards and national practice.
08Neem deel
Take part in Health and Society
Begin by wie u is.
Roetes
Roete
Nasionale instellings
Ministeries, statistiekkantore en agentskappe: 'n nasionale lessenaar en tak, en 'n setel in die werkgroepe. Nasionale hoofstukke
Roete
Sektore en beroepe
Operators, regulators, banks, insurers and professional bodies whose work touches health and society. For organisations
Roete
Leer
Kursusse en praktyk, met 'n rekord van elke voltooide kursus. Gratis om te studeer. Oop leer
Roete
Standaarde
Stel die metodes en datastandaarde saam met die werkgroepe op, hersien en aanvaar dit. Werkgroepe
Roete
Gemeenskappe en navorsing
Universities, civil society and individual experts: projects, data and review. Write to the Academy
Oop oproepe
| Oop oproep | Soek | Sluit |
|---|---|---|
| Stigtingsoproep vir kundiges vir die werkgroepe CALL-FOUNDING-EXPERTS | kundige, redakteur, voorsitter | 2026-12-15 |
| Oop nominasie vir die drie onafhanklike kundigesetels van die Wêreldwye Standaarderaad CALL-GSC-IND | raadslid | 2026-12-01 |
| Nominasies van tussentydse streekslede (geld slegs as daar oor die oorgangsbepaling besluit word) CALL-GSC-REG | raadslid | 2026-12-15 |
| Hersiening van die uiteensettings van die golf-1-risikokern (C1, C2, C3, C4, C8, C10, C11) CALL-REVIEW-WAVE1 | bydraer | 2027-01-31 |
| Kundiges vir die kernstandaarde van risikowetenskap: onsekerheid en gradering van bewyse, skale, gestruktureerde kundige oordeel, aanvaarbaarheid, uiterstes en saamgestelde gebeure, katastrofiese en eksistensiële risiko, etiek en billikheid, eenhede en meting (NRS-C17 tot NRS-C24) CALL-CORE-SCIENCE | kundige, redakteur, voorsitter | 2027-01-31 |
| Onafhanklike beoordelaars vir die families van die gevaar-atlas, drie uit minstens twee streke vir elke familie (NHS2-R19), prioriteitsfamilies eerste CALL-ATLAS-REVIEW | kundige | 2027-03-31 |
| Lede van die tussentydse Frontier Safety Review Panel en rooispanbeoordelaars (biologiese veiligheid en biosekuriteit, KI-veiligheid en -sekuriteit, sekuriteit van kritieke infrastruktuur); aansoeke word vertroulik hanteer CALL-FRONTIER-SAFETY-REVIEW | kundige | 2026-11-30 |
| Kundiges in ontologie, metrologie, sagtewareverifikasie en konformiteitsbeoordeling vir die vereisteregister, die NHS-2-masjienvoorstelling, die konformiteitstoetsreekse en die konformiteitsbeoordelingskema CALL-CONFORMANCE-ONTOLOGY | kundige, redakteur | 2027-01-31 |
Oproepe ná hul sluitingsdatum word outomaties versteek. Elke oproep, voorstel en roete: oop gebiede en oproepe.
Selle en CERT's
Bring die sel bymekaar
Bring drie tot sewe mense met aanvullende vaardighede bymekaar: data, veldpraktyk, beleid en kommunikasie.
Registreer dit
Write to the team with the cell's name, members, area and region. You receive a reference and a contact. Write to the Academy
Kies 'n handves
Kies een fokus: navorsing en bewyse, data en kaarte, hersiening van standaarde, of gemeenskapsgereedheid.
Leer saam
Volg gedeelde studiepaaie by Risk Academy, met praktyk en 'n rekord van elke voltooide kursus. Gevare en veerkragtigheid
Lei en rapporteer
Hold regular sessions. Publish what the cell learns through Reports. Bring findings to the working groups. Working groups
Spesialiseer as 'n Gemeenskapsnoodreaksiespan (CERT)
A CERT prepares its neighbourhood for the hazards it faces. It builds a local hazard profile from this site's map. It trains in household and street preparedness. It learns first aid and light search through recognised local providers, and it runs drills. A CERT works alongside the local emergency services and follows their direction. It never replaces them and is not an emergency service.
Die Indeks
What a national team or a local community can do on The Global Risks Index (NXS-GRX) today.
NXS-GRX
Your country's profile
Oop risikoprofiele vir 195 lande, met bronne en lisensies by elke waarde. Open die Indeks
NXS-GRX
Korrigeer of antwoord
Korrigeer 'n waarde of antwoord namens jou land. Die verandering word met sy effek aangeteken. Open die Indeks
NXS-GRX
Bied data aan
Bied 'n datastel aan. Dit kom deur die lisensiehek in, met erkenning aan jou. Open die Indeks
NXS-GRX
Gebruik die oop data
Lae, profiele en teëls deur die oop API. Open die Indeks
09References
Core references and where to begin
Start with World Health Organization, then World Health Organization, then National Research Council.
- World Health Organization, Laboratory biosafety manual, fourth edition (2020). who.int
- World Health Organization, Global guidance framework for the responsible use of the life sciences (2022). who.int
- National Research Council, Biotechnology research in an age of terrorism (2004). DOI
- Lipsitch and Inglesby, Moratorium on research intended to create novel potential pandemic pathogens (2014). DOI
- National Academies of Sciences, Engineering, and Medicine, Biodefense in the age of synthetic biology (2018). DOI
- Fauci, Research on highly pathogenic H5N1 influenza virus: the way forward (2012). DOI
- Yuste and others, Four ethical priorities for neurotechnologies and AI (2017). DOI
- Ienca and Andorno, Towards new human rights in the age of neuroscience and neurotechnology (2017). DOI
10Vrae
Vrae, antwoorde en kernterme
Is studie hier gratis?
Ja. Elke kursus en leermateriaal van Risk Academy, gelei deur die Nexus Consortium, is gratis om te studeer, op eie tempo of saam met 'n groep. Gewone deelname het geen fooi nie; betaalde werk, internskappe en genootskappe is afsonderlike reëlings.
Wat gee die voltooiing van 'n kursus my?
'n Voltooiingsrekord: die kursus, sy weergawe, die datum en wat geassesseer is, by verstek privaat en deur u gedeel. Dit stapel op tot dissipline-, departements- en programprestasies. 'n Rekord meld wat bestudeer en geassesseer is en sertifiseer nie bevoegdheid nie; dit is nie 'n lisensie, 'n professionele titel of 'n indiensnemingstatus nie.
Waar kom die data en die plekke vandaan?
Elke fakulteit onderrig op 'n tweeling van 'n werklike plek wat uit oop data gebou is; elke laag dra sy verskaffer, lisensie en datum, en elke resultaat op die Akademie vermeld sy bron. Kaarte en figure is aanwysers vir onderrig, nooit 'n assessering van 'n plek nie.
How do I take part beyond the courses in biotechnology, biosecurity and neurotechnology?
Vorm 'n bevoegdheidsel van drie tot sewe mense, bestudeer 'n gedeelde roete, neem 'n opdrag onder toesig in die Nasionale Werkgroepe, of bring 'n groep van jou instelling. Vir organisasies.
Kernterme
- Biosafety
- Practices and controls that prevent unintended exposure to or release of biological agents.
- Biosekuriteit
- Measures that prevent the loss, theft or misuse of biological agents and knowledge.
- Dual-use research of concern
- Life sciences research that could be misapplied to cause harm.
- Medical countermeasure
- A vaccine, therapeutic or diagnostic used against a health threat.
VerslaeDra by
Dra bewyse vanaf hierdie bladsy by.
Reports is die Konsortium se kwartaallikse publikasie. Wat jy oor hierdie onderwerp weet, kan in die volgende uitgawe bewyse, 'n gevallestudie of 'n regstelling word, aan jou toegeskryf en gepubliseer onder CC BY 4.0 waar dit jou eie werk is.
Risk Academy
- EmailGateway GW-ACADEMY Send it from this page Evidence, a correction, a case, a method, a review, a translation or profile input. It arrives tagged with this page, so the editor who owns it receives it.
- ZenodoOpen deposit Deposit it and submit to the community Publish your own record on Zenodo with your ORCID iD, then submit it to the Reports community there. Curators review it; the DOI stays yours.
- ReportsRisk Academy See every way to contribute The contribution types, how each is reviewed, what credit you receive, the licence and what is never accepted.
Stuur nooit persoonlike data, sensitiewe infrastruktuurbesonderhede of enigiets wat u geen reg het om te deel nie. 'n Bydrae word voor gebruik beoordeel; die stuur daarvan verleen geen outeurskap of redaksionele regte nie, en borgskap koop nooit 'n bevinding nie.
Biotegnologie, biosekuriteit en neurotegnologie
Prepare with a related course
Open courses in connected disciplines teach the methods this discipline will build on.
Blaai deur die kursuskatalogusBack to Department of Global Health Security